NEW AND IMPROVED FLAT/SLIDING FEE PROGRAM. For more information click on learn more or contact our office at 843-309-8301.
CareSouth Carolina is now administering 3rd doses of COVID-19 Vaccine to qualifying individuals.
The FDA has amended the EUA (Emergency Use Authorization) for Moderna and Pfizer COVID-19 vaccinations to allow for a third dose administration in individuals aged 12 and up who are moderately or severely immunocompromised with one of the following health conditions:
Third doses for any other patients have NOT been approved at this time.
A doctor’s order is not required for to receive the third dose, however you must sign an attestation statement certifying that you have been diagnosed with one of the above condition.
The third dose must be given at least 28 days after you received your second dose. You must have an appointment. Call your local CareSouth Carolina office to schedule.
*If you are unsure if you have one of the above listed conditions, please consult with your primary care provider who can help you decide if a third dose of COVID-19 vaccine is right for you.
If you would like to receive the third dose of the COVID-19 vaccine at a CareSouth Carolina office location, you can make an appointment or walk-in at one of the days and sites listed below:
Monday:
Tuesday:
Wednesday:
Thursday:
Friday:
What is the difference between a booster dose and an additional dose (third dose)?
Sometimes people who are moderately to severely immunocompromised do not build enough (or any) protection when they first get a vaccination. When this happens, getting another dose of the vaccine can sometimes help them build more protection against the disease. In contrast, a “booster dose” refers to another dose of a vaccine that is given to someone who built enough protection after vaccination, but then that protection decreased over time (this is called waning immunity).
*Please look for information on CareSouth Carolina website in September on booster doses. We are currently NOT offering booster doses. The FDA is still reviewing data and is expected to authorize booster doses in late September.